UK markets closed
NIKKEI 225
38,202.37 -632.73 (-1.63%) HANG SENG
18,313.86 -165.51 (-0.90%) CRUDE OIL
79.09 +0.71 (+0.91%) GOLD FUTURES
2,320.30 -3.90 (-0.17%) DOW
39,021.54 +137.28 (+0.35%) Bitcoin GBP
50,017.20 -563.60 (-1.11%)
Harvard Bioscience, Inc. (HBIO)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 03:06PM EDT. Market open.
| Previous close | 3.7500 |
| Open | 3.6500 |
| Bid | 3.6400 x 100 |
| Ask | 3.8200 x 100 |
| Day's range | 3.6500 - 3.8700 |
| 52-week range | 3.4400 - 6.2000 |
| Volume | |
| Avg. volume | 92,480 |
| Market cap | 162.07M |
| Beta (5Y monthly) | 1.45 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0800 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 6.88 |
Insider MonkeyHarvard Bioscience, Inc. (NASDAQ:HBIO) Q1 2024 Earnings Call Transcript
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q1 2024 Earnings Call Transcript May 7, 2024 Harvard Bioscience, Inc. misses on earnings expectations. Reported EPS is $-0.10815 EPS, expectations were $0.02. Harvard Bioscience, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, […]
- GuruFocus.com
Harvard Bioscience Inc (HBIO) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...
Despite a revenue dip, HBIO maintains robust margins and advances strategic initiatives to bolster future growth.
GuruFocus.comHarvard Bioscience Inc (HBIO) Q1 2024 Earnings: Challenges Persist Amidst Strategic Adjustments
First Quarter Reveals Revenue Decline and Net Loss, Despite Strong Gross Margin
© 2024 Yahoo. All rights reserved.